The estimated Net Worth of Advisors Llc Orbi Med Capit... is at least $239 Millón dollars as of 29 September 2017. Advisors Capit owns over 672,000 units of Otonomy Inc stock worth over $317,982 and over the last 12 years Advisors sold OTIC stock worth over $238,367,656.
Advisors has made over 17 trades of the Otonomy Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Advisors sold 672,000 units of OTIC stock worth $18,984,000 on 29 September 2017.
The largest trade Advisors's ever made was selling 672,000 units of Otonomy Inc stock on 29 September 2017 worth over $18,984,000. On average, Advisors trades about 113,657 units every 70 days since 2012. As of 29 September 2017 Advisors still owns at least 4,129,638 units of Otonomy Inc stock.
You can see the complete history of Advisors Capit stock trades at the bottom of the page.
Over the last 10 years, insiders at Otonomy Inc have traded over $30,282,796 worth of Otonomy Inc stock and bought 755,065 units worth $12,114,945 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Holdings A/S Novo y Brian H Dovey. On average, Otonomy Inc executives and independent directors trade stock every 66 days with the average trade being worth of $7,317. The most recent stock trade was executed by Vickie L Capps on 28 November 2022, trading 42,242 units of OTIC stock currently worth $4,224.
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
Otonomy Inc executives and other stock owners filed with the SEC include: